CDM\臺灣藥品藥理治療分類ATC碼 - TTL Representation

共同資料模式實作指引(Common Data Model IG)
1.0.0-Trial Use - draft
共同資料模式實作指引(Common Data Model IG) - Local Development build (v1.0.0-Trial Use). See the Directory of published versions
: 臺灣藥品藥理治療分類ATC碼 - TTL Representation

Active as of 2014-09-19

@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:CodeSystem ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "medcation-atc-tw"] ; # 
  fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This code system <code>https://twcore.mohw.gov.tw/fhir/CodeSystem/medcation-atc-tw</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">A10BD27<a name=\"medcation-atc-tw-A10BD27\"> </a></td><td>metformin, linagliptin and empagliflozin</td></tr><tr><td style=\"white-space:nowrap\">A16AB22<a name=\"medcation-atc-tw-A16AB22\"> </a></td><td>avalglucosidase alfa</td></tr><tr><td style=\"white-space:nowrap\">C03DA05<a name=\"medcation-atc-tw-C03DA05\"> </a></td><td>finerenone</td></tr><tr><td style=\"white-space:nowrap\">D11AH08<a name=\"medcation-atc-tw-D11AH08\"> </a></td><td>abrocitinib</td></tr><tr><td style=\"white-space:nowrap\">G04BD14<a name=\"medcation-atc-tw-G04BD14\"> </a></td><td>imidafenacin</td></tr><tr><td style=\"white-space:nowrap\">H01BA06<a name=\"medcation-atc-tw-H01BA06\"> </a></td><td>argipressin</td></tr><tr><td style=\"white-space:nowrap\">J05AB04<a name=\"medcation-atc-tw-J05AB04\"> </a></td><td>ribavirin</td></tr><tr><td style=\"white-space:nowrap\">J05AX11<a name=\"medcation-atc-tw-J05AX11\"> </a></td><td>elvitegravir</td></tr><tr><td style=\"white-space:nowrap\">J05AX12<a name=\"medcation-atc-tw-J05AX12\"> </a></td><td>dolutegravir</td></tr><tr><td style=\"white-space:nowrap\">J05AX67<a name=\"medcation-atc-tw-J05AX67\"> </a></td><td>ombitasvir, paritaprevir and ritonavir</td></tr><tr><td style=\"white-space:nowrap\">J05AX68<a name=\"medcation-atc-tw-J05AX68\"> </a></td><td>elbasvir and grazoprevir</td></tr><tr><td style=\"white-space:nowrap\">L01FX18<a name=\"medcation-atc-tw-L01FX18\"> </a></td><td>amivantamab</td></tr><tr><td style=\"white-space:nowrap\">L01XE01<a name=\"medcation-atc-tw-L01XE01\"> </a></td><td>imatinib</td></tr><tr><td style=\"white-space:nowrap\">L01XE03<a name=\"medcation-atc-tw-L01XE03\"> </a></td><td>erlotinib</td></tr><tr><td style=\"white-space:nowrap\">L01XE06<a name=\"medcation-atc-tw-L01XE06\"> </a></td><td>dasatinib</td></tr><tr><td style=\"white-space:nowrap\">L01XE10<a name=\"medcation-atc-tw-L01XE10\"> </a></td><td>everolimus</td></tr><tr><td style=\"white-space:nowrap\">L01XE11<a name=\"medcation-atc-tw-L01XE11\"> </a></td><td>pazopanib</td></tr><tr><td style=\"white-space:nowrap\">L01XE31<a name=\"medcation-atc-tw-L01XE31\"> </a></td><td>nintedanib</td></tr><tr><td style=\"white-space:nowrap\">L01XX14<a name=\"medcation-atc-tw-L01XX14\"> </a></td><td>tretinoin</td></tr><tr><td style=\"white-space:nowrap\">L01XX17<a name=\"medcation-atc-tw-L01XX17\"> </a></td><td>topotecan</td></tr><tr><td style=\"white-space:nowrap\">L01XX19<a name=\"medcation-atc-tw-L01XX19\"> </a></td><td>irinotecan</td></tr><tr><td style=\"white-space:nowrap\">L01XX32<a name=\"medcation-atc-tw-L01XX32\"> </a></td><td>bortezomib</td></tr><tr><td style=\"white-space:nowrap\">L01XX73<a name=\"medcation-atc-tw-L01XX73\"> </a></td><td>sotorasib</td></tr><tr><td style=\"white-space:nowrap\">L04AA52<a name=\"medcation-atc-tw-L04AA52\"> </a></td><td>ofatumumab</td></tr><tr><td style=\"white-space:nowrap\">N05CM21<a name=\"medcation-atc-tw-N05CM21\"> </a></td><td>lemborexant</td></tr></table></div>"
  ] ; # 
  fhir:url [ fhir:v "https://standard-interoperability-lab.com/fhir/CodeSystem/medcation-atc-tw"^^xsd:anyURI] ; # 
  fhir:version [ fhir:v "1.0.0-Trial Use"] ; # 
  fhir:name [ fhir:v "TWMedcationATC"] ; # 
  fhir:title [ fhir:v "臺灣藥品藥理治療分類ATC碼"] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:experimental [ fhir:v "false"^^xsd:boolean] ; # 
  fhir:date [ fhir:v "2014-09-19"^^xsd:date] ; # 
  fhir:publisher [ fhir:v "共同資料模式實作指引(Common Data Model IG)"] ; # 
  fhir:contact ( [
    ( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://ghd.tw/" ]     ] )
  ] ) ; # 
  fhir:description [ fhir:v "臺灣藥品藥理治療分類ATC碼，參照至[https://data.gov.tw/dataset/9119](https://data.gov.tw/dataset/9119)，資料提供單位：衛生福利部食品藥物管理署。  \r\n此代碼為WHO ATC(http://www.whocc.no/atc)中未涵蓋之代碼，為符合國內代碼使用，故將未被定義之代碼另外呈現。  \r\n\r\n*因原始資料無代碼版本資訊，故使用其「更新日期」作為版本資訊。*"] ; # 
  fhir:copyright [ fhir:v "衛生福利部食品藥物管理署"] ; # 
  fhir:caseSensitive [ fhir:v "true"^^xsd:boolean] ; # 
  fhir:content [ fhir:v "complete"] ; # 
  fhir:count [ fhir:v "25"^^xsd:nonNegativeInteger] ; # 
  fhir:concept ( [
fhir:code [ fhir:v "A10BD27" ] ;
fhir:display [ fhir:v "metformin, linagliptin and empagliflozin" ]
  ] [
fhir:code [ fhir:v "A16AB22" ] ;
fhir:display [ fhir:v "avalglucosidase alfa" ]
  ] [
fhir:code [ fhir:v "C03DA05" ] ;
fhir:display [ fhir:v "finerenone" ]
  ] [
fhir:code [ fhir:v "D11AH08" ] ;
fhir:display [ fhir:v "abrocitinib" ]
  ] [
fhir:code [ fhir:v "G04BD14" ] ;
fhir:display [ fhir:v "imidafenacin" ]
  ] [
fhir:code [ fhir:v "H01BA06" ] ;
fhir:display [ fhir:v "argipressin" ]
  ] [
fhir:code [ fhir:v "J05AB04" ] ;
fhir:display [ fhir:v "ribavirin" ]
  ] [
fhir:code [ fhir:v "J05AX11" ] ;
fhir:display [ fhir:v "elvitegravir" ]
  ] [
fhir:code [ fhir:v "J05AX12" ] ;
fhir:display [ fhir:v "dolutegravir" ]
  ] [
fhir:code [ fhir:v "J05AX67" ] ;
fhir:display [ fhir:v "ombitasvir, paritaprevir and ritonavir" ]
  ] [
fhir:code [ fhir:v "J05AX68" ] ;
fhir:display [ fhir:v "elbasvir and grazoprevir" ]
  ] [
fhir:code [ fhir:v "L01FX18" ] ;
fhir:display [ fhir:v "amivantamab" ]
  ] [
fhir:code [ fhir:v "L01XE01" ] ;
fhir:display [ fhir:v "imatinib" ]
  ] [
fhir:code [ fhir:v "L01XE03" ] ;
fhir:display [ fhir:v "erlotinib" ]
  ] [
fhir:code [ fhir:v "L01XE06" ] ;
fhir:display [ fhir:v "dasatinib" ]
  ] [
fhir:code [ fhir:v "L01XE10" ] ;
fhir:display [ fhir:v "everolimus" ]
  ] [
fhir:code [ fhir:v "L01XE11" ] ;
fhir:display [ fhir:v "pazopanib" ]
  ] [
fhir:code [ fhir:v "L01XE31" ] ;
fhir:display [ fhir:v "nintedanib" ]
  ] [
fhir:code [ fhir:v "L01XX14" ] ;
fhir:display [ fhir:v "tretinoin" ]
  ] [
fhir:code [ fhir:v "L01XX17" ] ;
fhir:display [ fhir:v "topotecan" ]
  ] [
fhir:code [ fhir:v "L01XX19" ] ;
fhir:display [ fhir:v "irinotecan" ]
  ] [
fhir:code [ fhir:v "L01XX32" ] ;
fhir:display [ fhir:v "bortezomib" ]
  ] [
fhir:code [ fhir:v "L01XX73" ] ;
fhir:display [ fhir:v "sotorasib" ]
  ] [
fhir:code [ fhir:v "L04AA52" ] ;
fhir:display [ fhir:v "ofatumumab" ]
  ] [
fhir:code [ fhir:v "N05CM21" ] ;
fhir:display [ fhir:v "lemborexant" ]
  ] ) . #
IG © 2023+ 共同資料模式實作指引(Common Data Model IG). Package CDM#1.0.0-Trial Use based on FHIR 4.0.1. Generated 2023-07-26
Links: Table of Contents | QA Report